Literature DB >> 18463448

Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.

Colin Buckley1, Vibeke Hoffmann, Jerry Shapiro, Seppo Saari, Frederic Cambazard, Mette Milsgaard.   

Abstract

BACKGROUND: There is a need for more effective therapy for scalp psoriasis.
OBJECTIVE: To assess the efficacy and safety of a 2-compound scalp formulation including calcipotriol and betamethasone dipropionate in the treatment of scalp psoriasis.
METHODS: Patients (n = 218) with scalp psoriasis were randomized to treatment with the 2-compound scalp formulation (n = 108) or betamethasone dipropionate in the same vehicle (n = 110). The treatments were applied once daily on the scalp for up to 8 weeks.
RESULTS: The 2-compound scalp formulation showed a significantly higher efficacy than betamethasone dipropionate on the total sign score at the end of treatment (p = 0.042) and after 2 weeks (p = 0.005).
CONCLUSION: The calcipotriol plus betamethasone dipropionate scalp formulation was superior to betamethasone dipropionate in the same vehicle when used once daily for up to 8 weeks in the treatment of scalp psoriasis. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463448     DOI: 10.1159/000130425

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  9 in total

Review 1.  [Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review].

Authors:  M A Radtke; K Herberger; T Kornek; M Augustin
Journal:  Hautarzt       Date:  2010-09       Impact factor: 0.751

2.  A study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasis.

Authors:  T A Luger; F Cambazard; F G Larsen; M Bourcier; G Gupta; F Clonier; P Kidson; N H Shear
Journal:  Dermatology       Date:  2008-09-12       Impact factor: 5.366

Review 3.  Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 4.  Topical treatments for scalp psoriasis.

Authors:  Justin Gabriel Schlager; Stefanie Rosumeck; Ricardo Niklas Werner; Anja Jacobs; Jochen Schmitt; Christoph Schlager; Alexander Nast
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

5.  Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.

Authors:  M Gooderham; J-M Debarre; J Keddy-Grant; Z Xu; M Kurvits; M Goodfield
Journal:  Br J Dermatol       Date:  2014-10-22       Impact factor: 9.302

Review 6.  Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach.

Authors:  Anupam Das; Saumya Panda
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

7.  Mechanisms of action of topical corticosteroids in psoriasis.

Authors:  Luís Uva; Diana Miguel; Catarina Pinheiro; Joana Antunes; Diogo Cruz; João Ferreira; Paulo Filipe
Journal:  Int J Endocrinol       Date:  2012-11-05       Impact factor: 3.257

Review 8.  Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation.

Authors:  Jonisha Shepherd; Arash Taheri; Steven R Feldman
Journal:  Clin Cosmet Investig Dermatol       Date:  2013-12-19

9.  Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris.

Authors:  George Kontochristopoulos; Anargyros Kouris; Athanasios Chantzaras; Athanasios Petridis; John Yfantopoulos
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.